You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 266 No. 3, July 17, 1991 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

{alpha}-Blocker Therapy of Hypertension

An Unfulfilled Promise

Alexander F. Khoury, MD; Norman M. Kaplan, MD

JAMA. 1991;266(3):394-398.


Abstract

For various reasons, the {alpha}1-receptor blocker prazosin has been used infrequently as initial therapy for hypertension. The introduction of additional agents of this class with properties different from prazosin provides slower onset of action, which should reduce the degree of first-dose and postural hypotension and a longer duration of action, which allows for once-a-day dosage. A summary of the published data on efficacy, side effects, and special properties of this class of agents indicates that they will probably be used more extensively, particularly because of their ability to improve lipid and glucose-insulin metabolism.

(JAMA. 1991;266:394-398)



Author Affiliations

From the Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Tex.


Footnotes

Reprint requests to University of Texas Southwestern Medical Center, Department of Internal Medicine, 5323 Harry Hines Blvd, Dallas, TX 75235-8899 (Dr Kaplan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Antihypertensive Agents on the Development of Type 2 Diabetes Mellitus
Stump et al.
Mayo Clin Proc. 2006;81:796-806.
ABSTRACT | FULL TEXT  

Hypertension and the Vascular Patient
Samson
VASC ENDOVASCULAR SURG 2004;38:103-119.
ABSTRACT  

Z-350, A Novel Compound with alpha 1-Adrenoceptor Antagonistic and Steroid 5alpha -Reductase Inhibitory Actions: Pharmacological Properties In Vivo
Fukuta et al.
J. Pharmacol. Exp. Ther. 1999;290:1013-1018.
ABSTRACT | FULL TEXT  

The Appropriate Goals of Antihypertensive Therapy: Neither Too Much Nor Too Little
Kaplan
ANN INTERN MED 1992;116:686-690.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.